type here...

CATEGORIES

Patient Advisories

LATEST

1234...6Page 3 of 6

TRENDING

EDITORS CHOICE

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Medika Life -
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

Deadly Superbug Candida Auris Hits Two Dallas Hospitals. Officials Won’t Name Hospitals

Medika Life -
A drug-resistant strain of Candida Auris has been detected in two Dallas Hospital's. Officials are endangering public health by not identifying the hospitals.

The New Covid Vaccine Trials. Has Moderna Just Crossed an Ethical Line?

Robert Turner, Founding Editor -
Moderna has just announced the launch of a new series of Covid Vaccine trials for its mRNA vaccine. These trials are to be held on children, some as young as six months.

68 Percent of Patients With Mild COVID-19 Get New Diagnosis Within 6 Months

Medika Life -
A worrying number of patients with an initially mild infection of Covid are developing long term conditions and symptoms that require medical attention. CDC suggest up 68 percent of us.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories